12 weeks 6-9 vials ~84 daily doses
Although the existing evidence in HFpEF is compelling, further trials seem warranted, particularly with respect to the effects of GLP-1 RAs on clinical outcomes and, possibly, in broader patient populations, such as patients with HFrEF or those without obesity.
Byrne said the most popular procedures GLP-1 users are turning to for their Ozempic face include full face and neck lifts plus lower eyelid surgery to tackle the toll of rapid weight loss
Pressure Mounts in a Surging and Politicized GLP-1 Market The companys move also reflects growing market and political scrutiny
The trial randomised 2,339 adults with obesity (or overweight with a weight-related comorbidity) and without type 2 diabetes to retatrutide 4mg, 9mg, or 12mg weekly (titrated upward from 2mg in four-weekly steps) or placebo